HOME › Analyst Briefings › Analyst Briefing Presentation on the “Bio-Implants Market - Global Trends &, Forecasts till 2017 ” to be held on September 24, 2012
Analyst Briefing Presentation on the “Bio-Implants Market - Global Trends &, Forecasts till 2017 ” to be held on September 24, 2012
The healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the “Bio-Implants Market (Cardiovascular, Orthopaedics, Neurostimulation, Xenografts, Allografts and Others) Competitive Analysis and Global Forecast to 2017” to be held on September 24, 2012
Bio-implants are defined as bioengineered products, employed in tissues or in human living cells with the assistance of active agents or synthetic constructs used to reproduce certain physiological functions or to treat the cause of the disease. They are used for medical as well as aesthetic purposes.
This report describes the growth opportunities in the global bio-implants market. It focuses on the increase in demand for technologically advanced products that may help in faster recovery and better efficacy of physiological body functions.
Rise in aging population, with increased focus on geriatric traumatology and geriatric surgeries; changing lifestyles; increased awareness about cosmetic implants; and innovation in implants technologies are the major drivers that are slated to propel this market. However, the pivotal factors restraining the growth of this market are the high cost of implants and complications associated with surgical implants.
The global bio-implants market was valued at $94.1 billion in the year 2012; North America was the largest bio-implants market, followed by Europe, and Asia. The U.S. market is expected to face a slump in the coming years due to austerity measures taken by the Federal Government and rise in taxation caused due to the economic crisis of 2008. Uncertainty also prevails in the European region with the Euro crisis; hence, growth is expected to be minimal in this region for the next five years. Asia, however, will showcase higher growth mainly due to large investments from foreign firms and government funding.
The major players in this market are Stryker Corporation (U.S.), Synthes (U.S.), Boston Scientific Corporation (U.S.), Biomet, Inc. (U.S.), Smith and Nephew (U.K.), Medtronic (U.S.), St. Jude Medical, Inc. (U.S.), and Tornier N.V. (The Netherlands).
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com